In Deutschland werden diese Meldungen durch das Bundesinstitut fr Arzneimittel und Medizinprodukte (BfArM) sowie das Paul-Ehrlich-Institut (PEI), Bundesinstitut fr Impfstoffe und biomedizinische Arzneimittel, bearbeitet
GLP-1 regulates glucose metabolism, promotes insulin secretion, and, crucially, induces satiety, thereby influencing appetite and food intake regulation
GLP-1s are no longer only useful for weight loss and diabetesthey are critical for building metabolic resilience and reducing inflammation, making them a powerful component of whole-person, lasting health
At the same time, employers must navigate rising pharmacy costs, utilization growth, and questions surrounding long-term adherence
In clinical trials, retatrutide is administered as a once-weekly subcutaneous injection
doi: 10.1007/s11011-021-00879-1 97 ZhuMGongD